Salim Yusuf

Salim Yusuf is one of the most influential cardiovascular researchers and clinical epidemiologists of the modern era. Born in 1952 in Bangalore, in the Indian state of Karnataka, into a Muslim family, he rose from modest beginnings in India to become a globally recognised authority whose studies have shaped the way heart disease is understood, prevented, and treated across every continent. His career embodies the conviction that careful, large-scale evidence, gathered honestly and shared widely, can save millions of lives, especially in the low- and middle-income countries where most of the world's people live.

Yusuf studied medicine at St John's Medical College in Bangalore, where he developed an early passion not only for treating individual patients but for understanding the patterns of disease across whole populations. He was drawn to the question that would define his life: why do so many people suffer heart attacks and strokes, and what can truly be done to prevent them? Seeking the best training available, he won a Rhodes Scholarship and travelled to the University of Oxford, where he completed his doctorate. At Oxford he worked alongside pioneers of clinical trial methodology, immersing himself in the still-young discipline of evidence-based medicine, the idea that medical decisions should rest on rigorous, quantitative proof rather than tradition or intuition.

During his Oxford years and his subsequent work, Yusuf became one of the early champions of the large, simple randomised trial and of the systematic combining of trial results, an approach that helped lay the foundations of modern meta-analysis. He recognised that to detect modest but genuine benefits of a treatment, and to be confident those benefits were real, studies needed to enrol very large numbers of patients across many hospitals and countries. This insight transformed cardiovascular medicine. Rather than relying on small, inconclusive studies, the field began to demand definitive evidence from trials enrolling thousands or tens of thousands of participants.

After spending part of his career in the United States at the National Institutes of Health, Yusuf moved to Canada, where he became a professor of medicine at McMaster University in Hamilton, Ontario. There he helped build the Population Health Research Institute into one of the world's foremost centres for cardiovascular and population research. As an Indian-born scholar who became a leading Canadian scientist, he came to symbolise the international and collaborative spirit of modern medical research, drawing colleagues and patients from dozens of nations into shared projects of discovery.

Yusuf's research achievements are extraordinary in both their scale and their impact. He led or co-led some of the most important clinical trials in the history of cardiology. The HOPE trial demonstrated that a class of drugs called ACE inhibitors could substantially reduce heart attacks, strokes, and deaths in people at high cardiovascular risk, even those who did not have high blood pressure, changing prescribing practice worldwide. He played a central role in trials establishing the benefits of beta-blockers, antiplatelet agents, and cholesterol-lowering strategies. His work on combination therapy and on the concept of a 'polypill', a single pill combining several proven medicines to prevent cardiovascular disease affordably, opened a path toward protecting people in poorer regions who could not access complex regimens.

Perhaps his most ambitious contribution is the family of global epidemiological studies he created to understand the true causes of heart disease across humanity. The INTERHEART study, examining heart attack patients in dozens of countries, showed that a small set of modifiable risk factors, including smoking, abnormal blood lipids, high blood pressure, diabetes, abdominal obesity, poor diet, inactivity, and psychosocial stress, accounted for the overwhelming majority of heart attacks everywhere in the world, regardless of region, ethnicity, or income. This finding carried a profound and hopeful message: most heart disease is preventable, and the same prevention strategies can work for all of humanity. He followed this with the vast PURE study, the Prospective Urban Rural Epidemiology study, which has tracked the diets, behaviours, and health of well over a hundred thousand people in many countries on multiple continents for years, producing a continuous stream of insights about nutrition, blood pressure, medication access, and the social determinants of health.

What distinguishes Yusuf is not only the brilliance of his methods but the moral purpose behind them. He has repeatedly drawn attention to the injustice that the burden of cardiovascular disease falls heaviest on the poor, both within wealthy nations and across the developing world, while research funding and effective treatments flow disproportionately to the rich. He has insisted that simple, inexpensive, proven interventions be made available to ordinary people everywhere. His advocacy reflects a deep ethical commitment, rooted in his upbringing and faith, to the dignity and worth of every human life, no matter how poor or distant.

Yusuf's productivity as a scholar is legendary. He has authored or co-authored an immense number of scientific papers, and for many years he has been counted among the most highly cited researchers in the world, an indication of how often other scientists build upon his findings. He has trained and mentored a large international community of researchers, many of whom now lead studies and institutions of their own. He served as president of the World Heart Federation, using that platform to press for global action against cardiovascular disease, the leading cause of death on the planet.

His achievements have been recognised with some of the highest honours in science and medicine. He is a Fellow of the Royal Society, one of the oldest and most prestigious scientific academies, and he has received the Canada Gairdner Wightman Award, among many other distinctions, along with senior national honours. Yet those who know him describe a man more interested in the next unanswered question, and in the patients his work might help, than in accolades.

The story of Salim Yusuf is, at its heart, a story of how patient, honest inquiry on a global scale can transform human health. He took the abstract tools of statistics and trial design and turned them toward the most pressing question of human survival, and in doing so he reshaped the daily practice of medicine for hundreds of millions of people. He demonstrated that a child born in Bangalore could grow to influence the health of the entire world, and that the same prevention that protects a patient in Canada can protect a farmer in rural Asia or Africa.

For young people, and especially for young Muslims who see in him a model of excellence joined to service, Yusuf offers a powerful example. He shows that the pursuit of knowledge can be an act of mercy, that scientific rigour and human compassion are not opposites but partners, and that the highest aim of learning is to relieve suffering and to lift up those who have the least. His life testifies that careful evidence, gathered with integrity and shared without barriers, is among the greatest gifts one human being can offer to all the others. In a world where heart disease remains the foremost cause of death, the work of Salim Yusuf continues to point the way toward a future in which far fewer families need lose the people they love.